Stockholm - Delayed Quote SEK
Genovis AB (publ.) (GENO.ST)
At close: 5:29 PM GMT+1
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.08 | 0.28 | 0.4 | 0.45 |
| Low Estimate | 0.07 | 0.07 | 0.4 | 0.4 |
| High Estimate | 0.1 | 0.5 | 0.4 | 0.5 |
| Year Ago EPS | -0.11 | 0.67 | 0.94 | 0.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 31.5M | 50.5M | 129M | 146.5M |
| Low Estimate | 30M | 28M | 127M | 126M |
| High Estimate | 33M | 73M | 131M | 167M |
| Year Ago Sales | -- | 27.31M | 158.23M | 129M |
| Sales Growth (year/est) | -- | 84.90% | -18.50% | 13.60% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.1 | 0.7 | 0.13 | 0.1 |
| EPS Actual | -0.11 | 0.67 | 0.19 | 0.03 |
| Difference | -0.21 | -0.03 | 0.06 | -0.07 |
| Surprise % | -210.00% | -4.30% | 46.20% | -70.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.08 | 0.28 | 0.4 | 0.45 |
| 7 Days Ago | 0.08 | 0.28 | 0.4 | 0.45 |
| 30 Days Ago | 0.09 | 0.29 | 0.4 | 0.45 |
| 60 Days Ago | 0.09 | 0.29 | 0.4 | 0.45 |
| 90 Days Ago | 0.11 | 0.31 | 0.7 | 0.76 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | GENO.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 172.70% | -- | -- | 5.40% |
| Next Qtr. | -58.20% | -- | -- | 12.70% |
| Current Year | -57.40% | -- | -- | 2.10% |
| Next Year | 12.50% | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
4FR.BE Faron Pharmaceuticals Oy
1.9180
+6.79%
FARN.L Faron Pharmaceuticals Oy
152.50
-3.17%
ATORX.ST Alligator Bioscience AB (publ)
0.7220
+9.06%
HNSA.ST Hansa Biopharma AB (publ)
33.34
+3.16%
GMAB Genmab A/S
23.11
+3.49%
ABCL AbCellera Biologics Inc.
2.7200
-1.45%
VRTX Vertex Pharmaceuticals Incorporated
502.45
+1.78%
VKTX Viking Therapeutics, Inc.
68.85
+4.52%